Virdante Pharmaceuticals
A privately held biopharmaceutical company focused on the development and commercialization of drugs for autoimmune and inflammatory disorders.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD80m (Public information from Dec 2011)
Cambridge Massachusetts (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$30.0m | Series A | ||
| N/A | $30.1m | Late VC | |
$51.5m Valuation: $51.5m | Acquisition | ||
| Total Funding | AUD92.9m | ||